Search Results - "Cresswell, D G"

Evolutionary dynamics of residual disease in human glioblastoma by Spiteri, I., Caravagna, G., Cresswell, G.D., Vatsiou, A., Nichol, D., Acar, A., Ermini, L., Chkhaidze, K., Werner, B., Mair, R., Brognaro, E., Verhaak, R.G.W., Sanguinetti, G., Piccirillo, S.G.M., Watts, C., Sottoriva, A.

“…Glioblastoma is the most common and aggressive adult brain malignancy against which conventional surgery and chemoradiation provide limited benefit. Even when…”
Get full text

The percutaneous absorption and excretion of promestriene (3-propoxy-17 beta-methoxy-1,3,5(10)-estratriene) in rats and humans by Moore, D H, Chasseaud, L F, Darragh, A, Taylor, T, Cresswell, D G

“…The percutaneous absorption of 3H-promestriene (an antiseborrhoeic agent; 3-propoxy-17 beta-methoxy-1,3,5(10)-estratriene) was studied in rats and human…”
Get more information

A pharmacokinetic study of repeated doses of a new controlled release form of ketoprofen by Houghton, G W, Dennis, M J, Templeton, R, Calvert, R M, Cresswell, D G

“…Nine volunteers were dosed once daily for 15 days with a controlled release formulation of ketoprofen. The peak plasma ketoprofen concentration (4.2…”
Get more information

The distribution excretion and biotransformation of p-dichloro[14C]benzene in rats after repeated inhalation, oral and subcutaneous doses by Hawkins, D R, Chasseaud, L F, Woodhouse, R N, Cresswell, D G

“…1. Following repeated daily whole-body exposure (3 h/day) of rats to atmospheres containing p-dichloro[14C]benzene (10000p.p.m.), or administration of oral or…”
Get more information

Toxicology studies of linear alkylbenzene sulphonate (LAS) in rhesus monkeys. II. The disposition of [14C] LAS after oral or subcutaneous administration by Cresswell, D G, Baldock, G A, Chasseaud, L F, Hawkins, D R

“…The disposition of radioactivity has been studied after administration of single and repeated oral or subcutaneous doses of [14C] LAS to rhesus monkeys. After…”
Get more information

Use of high-performance liquid chromatography to measure plasma concentrations of p-chlorophenoxyisobutric acid after administration of clofibrate to humans by Woodhouse, R N, Cresswell, D G, Chasseaud, L F, Brodie, R R

Get more information